Literature DB >> 3602931

Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.

P Stentoft, L Hendel, S Aggestrup.   

Abstract

Fifty-five patients with progressive systemic sclerosis (PSS) were evaluated with esophageal manometry, 12-h pH-probe monitoring in esophagus, and registration of symptoms of gastroesophageal reflux (GER). Thirty-nine patients had symptoms suggestive of GER. The 12-h pH-monitoring showed pathologic GER in 30 patients. We found that 33% of the patients with symptoms did not have pathologic GER, and 25% of the patients without symptoms had pathologic GER. Characteristic changes of impaired motility in the esophagus were found in 46 patients. When combining esophageal manometry, reflux measurement, and symptoms of GER, we found a positive correlation in 60% of patients with reduced peristalsis in the lower two-thirds of the esophagus and GER. We therefore recommend sensitive esophageal pH-monitoring in all PSS patients to ensure treatment of patients with pathologic GER.

Entities:  

Mesh:

Year:  1987        PMID: 3602931     DOI: 10.3109/00365528708991497

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Reproducibility of ambulatory esophageal pH monitoring in the aperistaltic esophagus.

Authors:  J P Shoenut; A B Mieflikier; T A Aldor; C S Yaffe; D J Goldenberg
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

2.  [Effect of cisapride on esophageal motility in healthy probands and patients with progressive systemic scleroderma].

Authors:  T Wehrmann; W F Caspary
Journal:  Klin Wochenschr       Date:  1990-06-19

3.  Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

Authors:  J R Murphy; P McNally; P Peller; S S Shay
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

4.  Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis.

Authors:  M Wegener; R J Adamek; B Wedmann; M Jergas; P Altmeyer
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

5.  Esophageal disease in progressive systemic sclerosis.

Authors:  Ellen C Ebert
Journal:  Curr Treat Options Gastroenterol       Date:  2008-02

6.  Systemic sclerosis and reflux.

Authors:  John J Petronovich; Jonathan M Bock
Journal:  Ear Nose Throat J       Date:  2013 Apr-May       Impact factor: 1.697

7.  Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis.

Authors:  J L Madsen; L Hendel
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

Review 8.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.